Finance

Beta
Lists
PHARMA:KLSE
Pharmaniaga Bhd
MYR 0.28
-5.17%
(-0.015) 1D
Jun 5, 4:38:23 PM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for PHARMA...
Open
MYR 0.29
High
MYR 0.29
Low
MYR 0.27
Mkt. cap
1.77B
Avg. vol.
15.77M
Volume
42.85M
Dividend
0.91%
Quarterly dividend
MYR 0.00
Ex-dividend date
Jun 5, 2026
P/E ratio
26.49
52-wk high
MYR 0.34
52-wk low
MYR 0.13
EPS
MYR 0.01
Shares outstanding
6.56B
No. of employees
4K
Open
MYR 0.29
High
MYR 0.29
Low
MYR 0.27
Mkt. cap
1.77B
Avg. vol.
15.77M
Volume
42.85M
Dividend
0.91%
Quarterly dividend
MYR 0.00
Ex-dividend date
Jun 5, 2026
P/E ratio
26.49
52-wk high
MYR 0.34
52-wk low
MYR 0.13
EPS
MYR 0.01
Shares outstanding
6.56B
No. of employees
4K
News stories
From sources across the web
Profile
Pharmaniaga Berhad is Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Wikipedia
About Pharmaniaga Bhd
CEOZulkarnain Md Eusope
Employees3.5K
Founded1994
Headquarters-
SectorHealth care provider
Websitepharmaniaga.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MYR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
926.86M
1.01B
938.28M
1.18B
Cost of goods sold
836.61M
911.96M
841.28M
1.05B
Cost of revenue
836.61M
911.96M
841.28M
1.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66.52M
73.17M
48.05M
73.51M
Operating expense
66.52M
73.17M
73.67M
73.51M
Total operating expenses
903.13M
985.13M
914.96M
1.12B
Operating income
23.74M
22.13M
23.32M
55.02M
Other non operating income
500.00K
482.00K
-2.18M
92.00K
EBT including unusual items
7.43M
10.36M
11.44M
46.41M
EBT excluding unusual items
7.43M
10.36M
11.18M
46.41M
Income tax expense
3.22M
2.87M
2.71M
14.22M
Effective tax rate
43.33%
27.67%
23.69%
30.64%
Other operating expenses
-
-
-
-
Net income
3.96M
7.28M
7.70M
31.47M
Net profit margin
0.43%
0.72%
0.82%
2.67%
Earnings per share
-
-
-
-
Interest and investment income
440.00K
2.39M
2.20M
1.38M
Interest expense
-17.24M
-14.65M
-12.17M
-10.08M
Net interest expenses
-16.80M
-12.26M
-9.96M
-8.70M
Depreciation and amortization charges
-
-
19.12M
-
EBITDA
117.31M
30.71M
30.81M
64.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer